Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Usoa E. Busto |
Documentos disponibles escritos por este autor (4)
Refinar búsquedaComparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital / Laurie A. Zawertailo en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 3 (Junio)
Título : Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital Tipo de documento: texto impreso Autores: Laurie A. Zawertailo, Autor ; Usoa E. Busto, Autor ; Howard L. Kaplan, Autor Fecha de publicación: 2023 Artículo en la página: pp. 269-280 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Barbitúricos, Comportamiento adictivo, Adicción - psicología, Meprobamato, Trastornos relacionados con sustancias, Triazolam. Resumen: Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedativehypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase). Link: ./index.php?lvl=notice_display&id=31023
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 3 (Junio) . - pp. 269-280[artículo] Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital [texto impreso] / Laurie A. Zawertailo, Autor ; Usoa E. Busto, Autor ; Howard L. Kaplan, Autor . - 2023 . - pp. 269-280.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 3 (Junio) . - pp. 269-280
Palabras clave: Barbitúricos, Comportamiento adictivo, Adicción - psicología, Meprobamato, Trastornos relacionados con sustancias, Triazolam. Resumen: Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedativehypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase). Link: ./index.php?lvl=notice_display&id=31023
Título : A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam Tipo de documento: texto impreso Autores: Usoa E. Busto, Autor ; Howard L. Kaplan, Autor ; C. Eugene Wright, Autor Fecha de publicación: 2023 Artículo en la página: pp. 628-635 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Afecto, Alprazolam, Ansiolíticos, Bromazepam, Lorazepam, Rendimiento psicomotor. Resumen: Sustained-release (SR) alprazolam may facilitate compliance with oral benzodiazepine treatment of panic disorders that currently requires doses administered three or four times daily. To compare the pharmacokinetic, psychomotor performance, and subjective effects of alprazolam SR (1.5 mg), bromazepam (3 mg taken three times daily), and lorazepam (1 mg taken three times daily), 13 male volunteers (aged 20-45 years) randomly received on four separate occasions one of these medications or placebo. Link: ./index.php?lvl=notice_display&id=31153
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 628-635[artículo] A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam [texto impreso] / Usoa E. Busto, Autor ; Howard L. Kaplan, Autor ; C. Eugene Wright, Autor . - 2023 . - pp. 628-635.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 628-635
Palabras clave: Afecto, Alprazolam, Ansiolíticos, Bromazepam, Lorazepam, Rendimiento psicomotor. Resumen: Sustained-release (SR) alprazolam may facilitate compliance with oral benzodiazepine treatment of panic disorders that currently requires doses administered three or four times daily. To compare the pharmacokinetic, psychomotor performance, and subjective effects of alprazolam SR (1.5 mg), bromazepam (3 mg taken three times daily), and lorazepam (1 mg taken three times daily), 13 male volunteers (aged 20-45 years) randomly received on four separate occasions one of these medications or placebo. Link: ./index.php?lvl=notice_display&id=31153
Título : Long-term benzodiazepine therapy does not result in brain abnormalities Tipo de documento: texto impreso Autores: Usoa E. Busto, Autor ; Karen E. Bremner, Autor ; Kathryn Knight, Autor Fecha de publicación: 2023 Artículo en la página: pp. 2-6 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Atrofia, Benzodiazepinas, Cerebro - diagnóstico por imágenes, Efectos cerebrales del medicamento. Resumen: Studies on the association between long-term benzodiazepine use and brain abnormalities have yielded conflicting results. The computed tomographic (CT) scans of 20 long-term users of benzodiazepine (65% men; mean age ± SD [range], 42 ± 12.1 years [23-59]; mean daily benzodiazepine dose [diazepam equivalents], 19.5 ± 16.2 mg [2.5-70]; mean cumulative benzodiazepine exposure, 55.2 g [1.8-198]) were compared with 36 age- (±3 years) and sex-matched controls. Link: ./index.php?lvl=notice_display&id=31224
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 1 (Febrero) . - pp. 2-6[artículo] Long-term benzodiazepine therapy does not result in brain abnormalities [texto impreso] / Usoa E. Busto, Autor ; Karen E. Bremner, Autor ; Kathryn Knight, Autor . - 2023 . - pp. 2-6.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 1 (Febrero) . - pp. 2-6
Palabras clave: Ansiolíticos, Atrofia, Benzodiazepinas, Cerebro - diagnóstico por imágenes, Efectos cerebrales del medicamento. Resumen: Studies on the association between long-term benzodiazepine use and brain abnormalities have yielded conflicting results. The computed tomographic (CT) scans of 20 long-term users of benzodiazepine (65% men; mean age ± SD [range], 42 ± 12.1 years [23-59]; mean daily benzodiazepine dose [diazepam equivalents], 19.5 ± 16.2 mg [2.5-70]; mean cumulative benzodiazepine exposure, 55.2 g [1.8-198]) were compared with 36 age- (±3 years) and sex-matched controls. Link: ./index.php?lvl=notice_display&id=31224
Título : The role of cytochrome p450 2c19 activity in flunitrazepam metabolism in vivo Tipo de documento: texto impreso Autores: Inbal Gafni M., Autor ; Usoa E. Busto, Autor ; Rachel F. Tyndale, Autor Fecha de publicación: 2023 Artículo en la página: pp. 169-175 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Cromatografía líquida, Citocromo P-450 CYP2C19, Flunitrazepam. Resumen: Flunitrazepam, a hypnotic benzodiazepine, is widely prescribed around the world for the treatment of insomnia and as a preanesthetic. In vitro studies have shown that the metabolism of flunitrazepam to desmethylflunitrazepam and 3-hydroxyflunitrazepam is mediated in part by the polymorphic enzyme CYP2C19. The objective was to examine the role of CYP2C19 activity in determining flunitrazepam kinetics in vivo. Link: ./index.php?lvl=notice_display&id=31034
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 2 (Abril) . - pp. 169-175[artículo] The role of cytochrome p450 2c19 activity in flunitrazepam metabolism in vivo [texto impreso] / Inbal Gafni M., Autor ; Usoa E. Busto, Autor ; Rachel F. Tyndale, Autor . - 2023 . - pp. 169-175.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 2 (Abril) . - pp. 169-175
Palabras clave: Ansiolíticos, Cromatografía líquida, Citocromo P-450 CYP2C19, Flunitrazepam. Resumen: Flunitrazepam, a hypnotic benzodiazepine, is widely prescribed around the world for the treatment of insomnia and as a preanesthetic. In vitro studies have shown that the metabolism of flunitrazepam to desmethylflunitrazepam and 3-hydroxyflunitrazepam is mediated in part by the polymorphic enzyme CYP2C19. The objective was to examine the role of CYP2C19 activity in determining flunitrazepam kinetics in vivo. Link: ./index.php?lvl=notice_display&id=31034
